CC
Chemours Co
13.70$
+1.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +270.8% | -160.2% | – | – | -0.7% | -181.2% | – | +57.0% | -6.2% | -132.1% | – | – | |
| – | +1.3% | -7.8% | +4.2% | +5.4% | +0.0% | +12.8% | +4.5% | -14.1% | +330.4% | -76.8% | +101.3% | – | |
| – | -16.7% | -80.0% | +500.0% | -16.7% | -40.0% | +66.7% | +40.0% | -28.6% | -20.0% | +75.0% | +100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +13.7% | -437.1% | – | – | +285.7% | -498.1% | – | -99.0% | +2,966.7% | -189.1% | – | – | |
| – | +57.0% | -24.4% | -28.4% | +4.1% | +43.4% | -22.9% | -48.8% | -4.7% | +9.8% | +8.9% | +89.8% | – | |
| – | +31.3% | -22.3% | -30.7% | +7.1% | +42.7% | -19.6% | -51.2% | -16.7% | +22.9% | +2.3% | – | – | |
| – | +0.0% | +0.0% | +0.0% | +2.7% | -5.3% | +2.8% | -64.9% | +0.0% | +15.4% | -13.3% | +100.0% | – | |
| – | -94.4% | +100.0% | -50.0% | – | +200.0% | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | -135.4% | – | -182.6% | +0.0% | -68.4% | +4,366.7% | – | |
| – | -101.5% | +980.0% | -25.9% | -32.5% | – | -167.1% | -52.6% | -81.5% | +640.0% | -48.6% | +1,521.1% | – | |
| – | -28.3% | -226.1% | – | – | +106.4% | -356.7% | – | +187.2% | -47.3% | -284.7% | – | – | |
| – | +688.6% | -213.0% | – | – | -54.0% | -775.9% | – | +110.0% | -12.4% | -201.1% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.